Miconazole Nitrate
Dosage & Administration Guidelines
| Species | Route | Dose | Frequency | Duration & Clinical Notes |
|---|---|---|---|---|
| Dog | Topical (cream, lotion, spray) | Apply to affected area | Twice daily (q12h) | Duration: 2-4 weeks; continue for 1 week after clinical resolution Notes: For otitis externa, use otic preparation; clean ear before application. |
| Cat | Topical (cream, lotion, spray) | Apply to affected area | Twice daily (q12h) | Duration: 2-4 weeks; continue for 1 week after clinical resolution Notes: For dermatophytosis, clip hair around lesions; use gloves to apply. |
| Horse | Topical (cream, lotion, spray) | Apply to affected area | Once to twice daily (q12-24h) | Duration: 2-4 weeks Notes: For ringworm, clip hair and remove crusts before application. |
| Cattle | Topical (spray, cream) | Apply to affected area | Once daily (q24h) | Duration: 2-4 weeks Notes: For ringworm, use spray for large areas; observe withdrawal times. |
| Small Ruminants (sheep, goats) | Topical (cream, spray) | Apply to affected area | Once daily (q24h) | Duration: 2-4 weeks Notes: Use cautiously in young animals; avoid excessive grooming. |
| Rabbit | Topical (cream, lotion) | Apply thin layer to affected area | Twice daily (q12h) | Duration: 2-4 weeks Notes: Prevent licking; use Elizabethan collar if necessary. |
| Birds/Poultry | Topical (cream, solution) | Apply to affected area | Once to twice daily (q12-24h) | Duration: 1-2 weeks Notes: For oral candidiasis, use oral suspension (off-label) with veterinary guidance. |
| Exotic (reptiles, small mammals) | Topical (cream, spray) | Apply to affected area | Once daily (q24h) | Duration: 2-4 weeks Notes: Ensure proper environmental humidity and temperature. |
Clinical Indications & Species Uses
- Topical treatment of superficial fungal infections caused by susceptible organisms
- Topical treatment of dermatophytosis (ringworm)
- Malassezia dermatitis
- Candidiasis (cutaneous and mucosal)
- Otitis externa (fungal or mixed)
- Secondary fungal infections in skin folds
- Dermatophytosis (ringworm)
- Malassezia dermatitis
- Candidiasis (oral, cutaneous)
- Otitis externa (fungal)
- Dermatophytosis (ringworm)
- Candidiasis (oral, cutaneous)
- Fungal keratitis (ophthalmic use, off-label)
- Dermatophytosis (ringworm)
- Candidiasis (oral, cutaneous)
- Teat lesions (fungal)
- Dermatophytosis (ringworm)
- Candidiasis (oral, cutaneous)
- Dermatophytosis (ringworm)
- Candidiasis (oral, cutaneous)
- Candidiasis (crop, oral)
- Dermatophytosis (rare)
- Dermatophytosis in reptiles (topical)
- Candidiasis in small mammals (topical)
Pharmacology & Mechanism of Action
Drug Class: Antifungal | Pharmacological Group: Azole antifungal (imidazole derivative)
Mechanism of Action: Miconazole nitrate inhibits the synthesis of ergosterol, a key component of the fungal cell membrane, by blocking the cytochrome P450-dependent enzyme lanosterol 14α-demethylase. This leads to increased membrane permeability, leakage of cellular contents, and ultimately fungal cell death. At higher concentrations, miconazole may also exert a direct fungicidal effect by interfering with membrane-bound enzymes and lipid biosynthesis.
Pharmacodynamics: Miconazole exhibits broad-spectrum antifungal activity against dermatophytes (e.g., Microsporum, Trichophyton), yeasts (e.g., Candida, Malassezia), and some dimorphic fungi. It is primarily fungistatic at low concentrations and fungicidal at higher concentrations. It also has some antibacterial activity against Gram-positive cocci. In veterinary medicine, it is often used topically for local fungal infections due to its good skin and mucosal penetration.
⚡ Pharmacokinetics Summary
Available Formulations & Strengths
Contraindications & Clinical Warnings
- Hypersensitivity to miconazole or other azole antifungals
- Hepatic impairment (for systemic use)
- Pregnancy (systemic use; topical use with caution)
- Do not use in eyes (except specific ophthalmic formulations)
- Concurrent use with certain drugs that prolong QT interval (systemic use)
- For topical use only unless otherwise directed; avoid contact with eyes and mucous membranes (unless specific formulation).
- Use with caution in animals with liver disease (systemic absorption possible through damaged skin).
- In food animals, observe withdrawal times.
- May cause local irritation or contact dermatitis.
- Do not use in animals with known hypersensitivity to azoles.
- In cats, avoid excessive grooming of treated areas; use Elizabethan collar if needed.
- For otic use, ensure tympanic membrane is intact.
- Use in pregnant or lactating animals only if clearly needed (topical use is generally considered low risk).
Adverse Effects & Reactions
Common:
- Local skin irritation (redness, itching, burning)
- Contact dermatitis
- Dryness or peeling of skin
Serious / Severe:
- Systemic toxicity (rare with topical use) - hepatotoxicity, QT prolongation (with systemic use)
- Anaphylaxis (rare)
- Bone marrow suppression (with systemic use)
Rare:
- Allergic reactions
- Endocrine disturbances (with systemic use)
- Drug interactions (with systemic use)
Key Drug Interactions
| Interacting Drug / Class | Clinical Effect & Mechanism | Severity |
|---|---|---|
| Warfarin and other oral anticoagulants | Miconazole may increase anticoagulant effect (inhibition of CYP2C9) leading to bleeding risk. | High |
| Phenytoin | Miconazole may increase phenytoin levels (CYP inhibition). | Moderate |
| Sulfonylureas (e.g., glipizide) | May enhance hypoglycemic effect. | Moderate |
| Cisapride, terfenadine, astemizole (with systemic use) | Risk of QT prolongation and cardiac arrhythmias. | High |
| Cyclosporine | May increase cyclosporine levels (CYP3A4 inhibition). | Moderate |
| Other azole antifungals (e.g., ketoconazole) | Additive antifungal effects but may increase risk of hepatotoxicity. | Moderate |
Overdose & Toxicity Management
Signs of Toxicity:
- Topical overdose: severe local irritation, erythema, blistering
- Systemic overdose (rare): nausea, vomiting, diarrhea, hepatotoxicity, QT prolongation, arrhythmias, respiratory depression
Emergency Treatment Protocol: For topical overdose, remove excess drug by washing with mild soap and water. For systemic overdose, provide symptomatic and supportive care; monitor liver function, ECG, and electrolytes. There is no specific antidote; consider activated charcoal if recent oral ingestion. In severe cases, hemodialysis may be considered (though not effective due to high protein binding).
Food Animal Withdrawal Times
No withdrawal times are established for topical miconazole in food animals; however, for extralabel use in food animals, consult a veterinarian and follow applicable regulations. For systemic use (not typical), withdrawal times may be longer.
Storage, Handling & Regulatory Information
Storage Temperature: Store at controlled room temperature 20-25°C (68-77°F); excursions permitted between 15-30°C (59-86°F).
Handling & Special Conditions: Keep container tightly closed. Do not freeze. Keep out of reach of children and animals.
Dispensing Status: Prescription Required (Rx Only)
Approval Status: Miconazole is not FDA-approved for veterinary use in the US; however, it is used extralabel in veterinary medicine. Some veterinary products containing miconazole (e.g., otic preparations) are approved.
Extra-Label (Off-Label) Use: In the US, miconazole is available as an OTC human product, but veterinary use is often extralabel. Under AMDUCA, extralabel use in food animals requires a valid veterinarian-client-patient relationship, and withdrawal times must be extended based on veterinary judgment. In the EU, similar regulations apply.
Clinical Pearls & Practice Notes
References & Literature
- 📚 Plumb's Veterinary Drug Handbook
- 📚 Papich Veterinary Pharmacology and Therapeutics
- 📚 Compendium of Veterinary Products (CVP)